AbCellera Biologics (ABCL)
NASDAQ:ABCL
Holding ABCL?
Track your performance easily

AbCellera Biologics (ABCL) Technical Analysis

1,541 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
AbCellera Biologics’s (ABCL) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting AbCellera Biologics is a Sell.
AbCellera Biologics’s (ABCL) 20-Day exponential moving average is 2.71, while AbCellera Biologics’s (ABCL) share price is $2.73, making it a Buy.
AbCellera Biologics’s (ABCL) 50-Day exponential moving average is 2.71, while AbCellera Biologics’s (ABCL) share price is $2.73, making it a Buy.

AbCellera Biologics (ABCL) Pivot Points

Nov 02, 2024, 07:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.61
2.66
2.69
2.74
2.77
2.82
2.85
Fibonacci
2.66
2.69
2.71
2.74
2.77
2.79
2.82
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbCellera Biologics (ABCL) Moving Averages

Nov 02, 2024, 07:42 AM
Period
Simple
Exponential
MA5
2.79Sell
2.76Sell
MA10
2.78Sell
2.75Sell
MA20
2.69Buy
2.71Buy
MA50
2.62Buy
2.71Buy
MA100
2.77Sell
2.92Sell
MA200
3.62Sell
3.59Sell
AbCellera Biologics’s (ABCL) 10-Day exponential moving average is 2.75, while AbCellera Biologics’s (ABCL) share price is $2.73, making it a Sell.
AbCellera Biologics’s (ABCL) 100-Day exponential moving average is 2.92, while AbCellera Biologics’s (ABCL) share price is $2.73, making it a Sell.
AbCellera Biologics’s (ABCL) stock price is $2.73 and AbCellera Biologics’s (ABCL) 50-day simple moving average is 2.62, creating a Buy signal.
AbCellera Biologics’s (ABCL) stock price is $2.73 and AbCellera Biologics’s (ABCL) 100-day simple moving average is 2.77, creating a Sell signal.
AbCellera Biologics’s (ABCL) stock price is $2.73 and AbCellera Biologics’s (ABCL) 200-day simple moving average is 3.62, creating a Sell signal.

AbCellera Biologics (ABCL) Technical Indicators

Nov 02, 2024, 07:42 AM
Name
Value
Implied Action
RSI (14)
52.09
Neutral
STOCH (9,6)
38.70
Neutral
STOCHRSI (14)
62.10
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
14.27
Buy
Williams %R
-46.34
Buy
CCI (14)
37.16
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
44.16
Neutral
ROC
8.33
Buy
AbCellera Biologics’s (ABCL) Relative Strength Index (RSI) is 52.09, creating a Neutral signal.
AbCellera Biologics’s (ABCL) Trend Strength Indicator (ADX) is 14.27, creating a Buy signal.
AbCellera Biologics’s (ABCL) Commodity Channel Index (CCI) is 37.16, creating a Neutral signal.
AbCellera Biologics’s (ABCL) Price Rate of Change (ROC) is 8.33, creating a Buy signal.

FAQ

Is ABCL a Buy, Hold, or Sell?
Based on ABCL’s technical indicators, ABCL is a Hold.
    What is ABCL’s RSI (14)?
    ABCL’s RSI (14) is 52.09, which suggests ABCL is a Neutral.
      What is ABCL’s MACD?
      ABCL’s MACD is 0.05, which suggests ABCL is a Sell.
        What is ABCL’s 5-day moving average?
        ABCL’s 5-day moving average is 2.79, which suggests ABCL is a Sell.
          What is ABCL’s 20-day moving average?
          ABCL 20-day moving average is 2.69, which suggests ABCL is a Buy.
            What is ABCL’s 50-day moving average?
            ABCL’s 50-day moving average is 2.62, which suggests ABCL is a Buy.
              What is ABCL’s 200-day moving average?
              ABCL’s 200-day moving average is 3.62, which suggests ABCL is a Sell.
                What is ABCL’s Williams % R (14)?
                ABCL’s Williams % R (14) is -46.34, which suggests ABCL is a Buy.
                  What is ABCL’s CCI (14)?
                  ABCL’s CCI (14) is 37.16, which suggests ABCL is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis